Library

Advies Medical Technology Assessment Deel I / Rijswijk [NL] : Raad voor Gezondheidsonderzoek (RGO) (1998)  

Advies Medical Technology Assessment Deel I : Inventarisatie van MTA-onderzoek en een aanzet tot coördinatie [printed text] . - Rijswijk [NL] : Raad voor Gezondheidsonderzoek (RGO), 1998 . - 35 p. : ill. ; A4. € 0,00 Languages : Dutch (dut) English (eng) Descriptors: Classification W 82 Biomedical technology (General) Indexation Health Policy ; Netherlands ; Technology Assessment, Biomedical Contents note: Samenvatting 1 -- Summary 5 -- 1. Inleiding 9 -- 2. Werkwijze 11 -- 2.1 Definitie MTA -- 2.2 MTA en doelmatigheid -- 2.3 Enquêtering -- 2.4 Werkwijze verwerking informatie -- 3. Resultaten van de enquête 15 -- 3.1 Respons enquête -- 3.2 Lacunes genoemd door de vraagzijde -- 3.3 Lacunes gesignaleerd door de aanbodzijde -- 3.4 Overzicht lopend MTA-onderzoek -- 4. Coördinatie MTA in Nederland 21 -- 5. Conclusies en aanbevelingen 23 -- Bijlage 1: Samenstelling van de commissie MTA 25 -- Bijlage 2: Organisaties aan de aanbodzijde MTA 27 -- Bijlage 3: Organisaties aan de vraagzijde MTA 29 -- Bijlage 4: Deelnemers invitational conference 31 -- Bijlage 5: Overzicht door vraag- en aanbodzijde genoemde lacunes in MTA 33 -- Bijlage 6: Lijst met afkortingen 37 Link for e-copy: http://www.gezondheidsraad.nl/sites/default/files/Advies%2015%20MTAdeel1.pdf Format of e-copy: PDF [Open Access] (200 KB) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2494

Alendroninezuur effectiever dan alfacalcidol voor preventie van osteoporose bij patiënten met een reumatische ziekte die starten met glucocorticoïdtherapie / R.N. de Nijs in Nederlands tijdschrift voor geneeskunde, 351(2007)21 ([05/26/2007])  

[article] Alendroninezuur effectiever dan alfacalcidol voor preventie van osteoporose bij patiënten met een reumatische ziekte die starten met glucocorticoïdtherapie = Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy [printed text] / R.N. de Nijs, Author ; J.W. Jacobs, Author ; W.F. Lems, Author ; R.F. Laan, Author ; E. Buskens, Author ; A. Algra, Author ; A.M. Huisman, Author ; Chris De Laet , Author . - 2007 . - 1178-85. Languages : Dutch (nla) in Nederlands tijdschrift voor geneeskunde > 351(2007)21 [05/26/2007] . - 1178-85 Descriptors: Classification W 1 Serials. Periodicals Indexation Disease ; Journal Article ; Netherlands ; Osteoporosis ; Peer Review ; Rheumatic Diseases ; Therapy Abstract: OBJECTIVE: To compare the effects of alendronate and alfacalcidol in the prevention ofglucocorticoid-related osteoporosis in patients with a rheumatic disease. DESIGN: Randomised, double-blind, double-placebo clinical trial (www. clinicaltrials.gov; number: NCT00138983). METHODS: A total of 201 patients with rheumatic disease who were starting glucocorticoid treatment at a daily dose that was equivalent to at least 7.5 mg of prednisone were randomised to alendronate (10 mg) and a placebo capsule ofalfacalcidol daily (n = 100) or alfacalcidol (1 microg) and a placebo tablet ofalendronate daily (n = 101) for 18 months. Primary outcome was change in lumbar spine bone mineral density at 18 months. The main secondary outcome was the incidence of morphometrically confirmed vertebral deformities. RESULTS: Overall, 163 patients completed the study. The bone mineral density of the lumbar spine increased by 2.1% (95% CI: 1.1-3.1) in the alendronate group and decreased by 1.9% (95% CI: -3.I--0.7) in the alfacalcidol group. At 18 months the mean difference in change in bone mineral density between the two groups was 4.0% (95% CI: 2.4-5-5). Three patients in the alendronate group had a new vertebral deformity, compared with 8 patients in the alfacalcidol group, including 5 symptomatic vertebral fractures in 3 patients; the hazard ratio was 0.4 (95% CI: 0.1-1.4). CONCLUSION: Alendronate was more effective than alfacalcidol in preventing glucocorticoid-induced bone loss during this 18-month trial in patients with rheumatic diseases who were starting glucocorticoid treatment. Link for e-copy: http://www.ntvg.nl/publicatie/alendroninezuur-effectiever-dan-alfacalcidol-voor- [...] Format of e-copy: VDIC IP recognition Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2152 [article]

An economic evaluation of varicella vaccination in Italian adolescents / Nancy Thiry in Vaccine, 22(2004)27-28 ([09/09/2004])  

[article] An economic evaluation of varicella vaccination in Italian adolescents [printed text] / Nancy Thiry, Author ; Philippe Beutels, Author ; Francesco Tancredi, Author ; A. Zanetti, Author ; Paolo Bonanni, Author ; Giovanni Gabutti, Author ; Pierre Van Damme, Author . - 2004 . - 3546-3562. Languages : English (eng) in Vaccine > 22(2004)27-28 [09/09/2004] . - 3546-3562 Descriptors: Classification W 1 Serials. Periodicals Indexation Adolescent ; Adult ; Age Factors ; Aged ; Chickenpox Vaccine ; Child ; Child, Preschool ; Cost of Illness ; Cost-Benefit Analysis ; Economics ; Encephalitis, Varicella Zoster ; Epidemiology ; Female ; Hospitalization ; Humans ; Italy ; Journal Article ; Male ; Markov Chains ; Mass Immunization ; Middle Aged ; Netherlands ; Peer Review ; prevention and control ; statistics and numerical data [Subheading] Abstract: An economic evaluation was performed to assess five varicella vaccination scenarios targeted to 11-year-old Italian adolescents. The scenarios were: "compulsory vaccination" of all adolescents, recommended vaccination of susceptible adolescents on the basis of an "anamnestic screening", a "blood test" or a combination of both ("both tests") and vaccination of adolescents in the private sector, at the parents' charge ("private vaccination"). Probabilities and unit costs were taken from published sources and experts opinion. The accuracy of the anamnestic screening (81.6% sensitivity and 87.3% specificity) was derived from a separate descriptive study among 344 Italian adolescents. The costs and benefits of each scenario were simulated using a Markov model and cost-effectiveness, budget-impact and cost-benefit analyses were conducted. Of all considered scenarios, "both tests" and "anamnestic screening" were the most appealing options with an estimated net direct cost of 5058 and 8929 per life-year gained (compared to no vaccination) versus 14,693-42,842 for the other scenarios. These two scenarios further resulted in substantial net savings for society (over 600,000 per cohort, BCR: 2.17). The need for a serological confirmation was highly dependent on the sensitivity of the anamnestic screening, which is believed to increase once such a program is launched. For practical considerations, "anamnestic screening" seems to be the most convenient option. Link for e-copy: http://tiny.cc/xktyn Format of e-copy: VDIC IP recognition Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1773 [article]

Association between physician density and health care consumption / Christian Léonard in Health Policy, 91(2009)2 ([07/01/2009])  

[article] Association between physician density and health care consumption : a systematic review of the evidence [printed text] / Christian Léonard , Author ; Sabine Stordeur, Author ; Dominique Roberfroid , Author . - 2009 . - 121-34. Languages : English (eng) in Health Policy > 91(2009)2 [07/01/2009] . - 121-34 Descriptors: Classification W 1 Serials. Periodicals Indexation 2006-27-2 ; Health Services ; Humans ; Journal Article ; Netherlands ; Peer Review ; Physicians ; R72 ; supply and distribution Abstract: BACKGROUND: Supplier-induced demand (SID) for health care could be a crucial factor of rising health expenditures. However, there is thus far no consensus on the topic. OBJECTIVE: To assess how physician density (physician-to-population ratio) and health care consumption correlate. METHODS: A systematic review of studies retrieved through electronic databases: Medline, Econlit, PsychINFO and Embase. Search, inclusion and quality appraisal were based on standard procedures and applied independently by two researchers. RESULTS: Twenty-five studies, generally of moderate quality, were included. Despite a substantial heterogeneity in study design and data modelling, a significant association between physician density and health care consumption was consistently observed. However, estimates varied according to a number of method parameters such as the definition of the dependent variable (physician volume or care intensity), the geographical entity or the medical specialty under consideration, and the adjustment for confounding factors. CONCLUSIONS: The exact importance of SID and the underlying motivations remain poorly understood. We discuss technical issues for better SID assessment. In the absence of more accurate information, limiting physician supply as a measure of cost containment should also be considered cautiously. Link for e-copy: http://dx.doi.org/10.1016/j.healthpol.2008.11.013 Format of e-copy: VDIC IP recognition Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2410 [article]

Atherosclerosis / S. Humphries / Amsterdam : Elsevier (1970)  

[serial]  See available issues Search in serial Atherosclerosis = Atherosclerosis [printed text] / S. Humphries, Publishing director . - Amsterdam : Elsevier, 1970. ISSN : 0021-9150 IF : http://www.elsevier.com.vdicp.health.fgov.be:8080/wps/find/journaldescription.cws_home/522790/description#description SJR : http://www.scimagojr.com/journalsearch.php?q=22483&tip=sid&clean=0 Indexed : MEDLINE (1970-....) Reader accessibility : http://jinfo.lub.lu.se/jinfo?func=fullRecord&jId=1852&issn=00219150 Languages : English (eng) Descriptors: Classification W 1 Serials. Periodicals Indexation Cardiology ; Netherlands ; Peer Review ; Periodicals ; Societies, Medical Abstract: Atherosclerosis brings together from all sources papers concerned with research and investigation on atherosclerosis, its complications, and related diseases, including: lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, disorders of lipid transport, diabetes and hypertension as related to atherosclerosis, and cardiovascular risk factors. The editors are also interested in clinical papers dealing with case studies of specific or general interest, new or unusual lipid syndromes, and the genetic basis and familial incidence of atherosclerosis and related diseases. High quality reports of controlled clinical trials of drugs or diets will be considered provided the paper deals with the mechanism of action of the drug or diet. Link for e-copy: http://vdic.idm.oclc.org/login?url=https://www.sciencedirect.com/journal/atheros [...] Format of e-copy: VDIC IP recognition (ScienceDirect, 1995 to present) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2180 [serial]  See available issues Search in serial

Beroepenregistraties / Utrchet [Netherlands] : Nederlands instituut voor onderzoek van de gezondheidszorg - NIVEL  

Permalink

Bulletin de l'Institut Pasteur / D.M. Ojcius / Amsterdam : Elsevier (1903-1998)  

Permalink

A candidate vaccine based on the hepatitis C E1 protein / Leroux-Roels, G in Vaccine, 22(2004)23-24 ([08/13/2004])  

Permalink

Cijfers uit de registratie van huisartsen / L. Hingstman / Utrchet [Netherlands] : Nederlands instituut voor onderzoek van de gezondheidszorg - NIVEL (2010)  

Permalink

Computer methods and programs in biomedicine / T. Groth / Amsterdam : Elsevier (1987)  

Permalink

Control of infectious diseases in refugee and displaced populations in developing countries / C. Paquet in Bulletin de l'Institut Pasteur, 96(1998)1 ([01/01/1998])  

Permalink

Convincing or confusing? / Philippe Beutels in Vaccine, 25(2007)8 ([02/09/2007])  

Permalink

Cost-effectiveness analyses of drug eluting stents versus bare metal stents / Mattias Neyt in Health Policy, 91(2009)2 ([07/01/2009])  

Permalink

Diliguide / Utrecht [The Netherlands] : Kwaliteitsinstituut voor de Gezondheidszorg (CBO) (2011)  

Permalink

Distribution and composition of HDL subclasses in students whose parents suffered prematurely from a myocardial infarction in comparison with controls / M. Rosseneu in Atherosclerosis, 63(1987)2-3 ([02/01/1987])  

Permalink